Austin Urology Institute Adopts New Bladder Cancer Imaging Technology
February 13, 2015
Austin Urology Institute was one of the first Austin urologists to incorporate narrow band imaging, which has vastly increased our ability to spot smaller, fainter tumors in the bladder. With this new technology installed, our ability to detect bladder cancer earlier for better outcomes.
More on narrow band imaging from KXAN News:
Here is a summary of the study from Kaiwen Li, Tianxin Lin, Xinxiang Fan, Yu Duan and Jian Huang published in the International Journal of Urology, September 2012.
DIAGNOSIS OF NARROW-BAND IMAGING (NBI) IN NON-MUSCLE-INVASIVE BLADDER CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS
The objective was to evaluate the diagnostic accuracy of cystoscopy assisted by Narrow-Band Imaging compared with white-light imaging for non-muscle invasive bladder cancer. This is the first systematic review and meta-analysis of studies with a patient comparison of NBI and White Light.
An electronic database search of PubMed, Embase, the Cochrane Library, Ovid and Web of Science was carried out for all articles comparing NBI with white-light imaging cystoscopy in the detection of non-muscle-invasive bladder cancer. A full meta-analysis review was performed following the guidelines of the Cochrane Collaboration (a not-for-profit organization with collaborators from over 120 countries working together to produce credible, accessible health information that is free from commercial sponsorship and other conflicts of interest).
- Seven studies with prospectively collected data including a total of 1040 patients were identified, and 611 patients with 1476 tumors were detected by biopsy
- Additional 17% of patients with NMIBC were visualized with NBI
- Additional 24% of tumors per patient were visualized by NBI b On the tumor level, an additional 28% of CIS was identified with NBI
- False positive rate did not differ significantly between the two groups